We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

104 hedge funds and large institutions have $1.41B invested in Ventyx Biosciences in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 29 increasing their positions, 20 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,367% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 3

245% more capital invested

Capital invested by funds: $408M → $1.41B (+$1B)

65% more funds holding

Funds holding: 63 → 104 (+41)

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

45% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 20

11.64% more ownership

Funds ownership: 68.1% → 79.74% (+12%)

12% less call options, than puts

Call options by funds: $1.97M | Put options by funds: $2.25M

Holders
104
Holders Change
+41
Holders Change %
+65.08%
% of All Funds
1.79%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.1%
New
44
Increased
29
Reduced
20
Closed
3
Calls
$1.97M
Puts
$2.25M
Net Calls
-$277K
Net Calls Change
-$277K

Top Buyers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$38.5M
2
DGM
Darwin Global Management
Jersey
+$31M
3
RG
Redmile Group
California
+$30.2M
4
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$23.7M
5
BC
Boxer Capital
California
+$18.8M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$23.6M
2
LGM
Logos Global Management
California
-$20.3M
3
EC
EcoR1 Capital
California
-$19.9M
4
FCM
Farallon Capital Management
California
-$19.1M
5
VC
Vivo Capital
California
-$12.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
76
Deutsche Bank
Germany
$348K -$26.3K -1,189 -11%
California State Teachers Retirement System (CalSTRS)
77
California State Teachers Retirement System (CalSTRS)
California
$309K -$16.2K -733 -8%
VOYA Investment Management
78
VOYA Investment Management
Georgia
$307K +$195K +8,786 New
VEA
79
Virtus ETF Advisers
New York
$280K +$1.17K +53 +0.7%
Two Sigma Advisers
80
Two Sigma Advisers
New York
$279K +$177K +8,000 New
TMAM
81
Tokio Marine Asset Management
Japan
$272K -$66.4K -3,000 -28%
Invesco
82
Invesco
Georgia
$241K +$153K +6,899 New
MC
83
Moors & Cabot
Massachusetts
$209K +$133K +6,000 New
Renaissance Technologies
84
Renaissance Technologies
New York
$202K +$128K +5,800 New
Royal Bank of Canada
85
Royal Bank of Canada
Ontario, Canada
$197K +$122K +5,495 +4,327%
Wells Fargo
86
Wells Fargo
California
$146K -$3.08K -139 -3%
SG Americas Securities
87
SG Americas Securities
New York
$132K +$83.8K +3,783 New
AB
88
Amalgamated Bank
New York
$126K +$1.2K +54 +2%
Barclays
89
Barclays
United Kingdom
$106K -$6.1M -275,335 -99%
Legal & General Group
90
Legal & General Group
United Kingdom
$94K +$6K +271 +11%
Citigroup
91
Citigroup
New York
$84K -$2.7M -122,104 -98%
SO
92
STRS Ohio
Ohio
$83K – – –
TRCT
93
Tower Research Capital (TRC)
New York
$70K +$4.05K +183 +10%
AIP
94
Ameritas Investment Partners
Nebraska
$58K – – –
MLICM
95
Metropolitan Life Insurance Company (MetLife)
New York
$52.8K – – –
HNWAG
96
High Net Worth Advisory Group
Florida
$35K +$11.1K +500 +100%
QT
97
Quantbot Technologies
New York
$22K +$14.4K +650 New
CG
98
Cutler Group
California
$17K +$11.1K +500 New
O
99
OrbiMed
New York
$7.86K -$23.6M -1,064,280 -83%
CS
100
Credit Suisse
Switzerland
$4K +$2.44K +110 +647%
1 2 3
4
5

VTYX Hedge Fund Activity: Q3 2022 in Review

104 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q3 2022, worth a combined $1.41B — up 245% from $408M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new VTYX positions and 3 closed out — a net gain of 41 holders — while 29 added to existing stakes and 20 trimmed.

The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $38.5M. The largest seller was OrbiMed, cutting an estimated $23.6M.

  • 104 institutional investors held Ventyx Biosciences (VTYX) as of Q3 2022, up from 63 in Q2 2022.
  • Funds reported $1.41B of Ventyx Biosciences stock for Q3 2022, up 245% quarter-over-quarter.
  • 44 funds opened new Ventyx Biosciences positions in Q3 2022 and 3 closed out, a net change of +41 holders.
  • The largest Ventyx Biosciences buyer in Q3 2022 was Lord, Abbett & Co, an estimated $38.5M added.
  • The largest Ventyx Biosciences seller in Q3 2022 was OrbiMed, an estimated $23.6M sold.

Based on aggregated 13F filings for Q3 2022.